Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials
Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
-
Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers
For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.
-
Benefits Of Implementing EDC & Medical Coding With RTSM
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Wearable DHT 101: Foundations For Use In Regulated Clinical Trials
Delve into the benefits of continuous sensor data, the scope of wearable use in clinical trials, and the specific sensors and measures employed by wearable DHTs.
-
Connecting The Right Patients To The Right Trial
Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.
-
Optimizing Integrated Registries
Integrated registries are vital to understanding disease progression, but effective integration requires a combination of data science, technical expertise, and IT architecture supporting real-world evidence generation.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
-
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch
Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
One Day, We Won't Need Placebos
Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).
-
How To Improve Patient Engagement In Clinical Trials
Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More